FDA Approves HIFU Clinical Trial For Recurrent Prostate Cancer

The FDA has announced its conditional approval, pending minor changes to the protocol, for a clinical trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 (HIFU) in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine will serve as the medical monitor [...]